Term
| Administer ______ to any suspected pt with a cardiopulmonary emergency. |
|
Definition
|
|
Term
| Naturally occurring ADH; Has no Beta properties |
|
Definition
|
|
Term
| Administer Oxygen to all patients for first _____ hours. Continue if what? (3 reasons) |
|
Definition
| 6; pulmonary congestion, ongoing ischemia, or SpO2 <90% |
|
|
Term
| Increases coronary & cerebral perfusion pressure and vital organ flow; Decreases V-Fib Frequency |
|
Definition
|
|
Term
| Used as an alternative to epinephrine for treatment of adult shock refractory V.F., asystole and PEA; useful for |
|
Definition
|
|
Term
| A side effect of this drug is intense peripheral vasoconstriction of skin, skeletal muscle, and fat. |
|
Definition
|
|
Term
| A side effect of this drug is less vasoconstriction of coronary and renal vascular beds and greater vasodilation of cerebral vasculature than epinephrine. |
|
Definition
|
|
Term
| Vasopressin is not recommended for responsive patients with CAD. Why? |
|
Definition
| Increases systemic vascular resistance (SVR)and may provoke cardiac ischemia and angina. |
|
|
Term
|
Definition
|
|
Term
|
Definition
| 40 U IV/IO X 1 dose (may replace either the first or second dose of epinephrine) |
|
|
Term
| If V. Fib continues after administration of Vasopressin, do not give epinephrine for how long? |
|
Definition
|
|
Term
| Has Alpha & Beta effects; increases contractility, atutomaticity and electrical activity in the heart; increase MVO2 |
|
Definition
|
|
Term
| Causes vasoconstriction; increases coronary & cerebral perfusion, although not as much as vasopressin |
|
Definition
|
|
Term
| Makes V. Fib more susceptible to defib |
|
Definition
|
|
Term
| This drug is indicated for Cardiac arrest, Symptomatic Bradycardia, Severe Hypotension, Anaphylaxis, Severe allergic reactions |
|
Definition
|
|
Term
| Used for Symptomatic Bradycardia after atropine as an alternative to Dopamine drip |
|
Definition
|
|
Term
| Used for Severe Hypotension when pacing and atropine fail, when hypotension accompanies bradycardia, or with phosphodiesterase enzyme inhibitor |
|
Definition
|
|
Term
|
Definition
For V/F or Pulseless VT: 1 mg of 1:10,000 solution IV/IP every 3-5 minutes as long as patient is pulseless.
ETT: 2-2.5 mg
Calcium channel block or beta blocker overdoes: Up to 0.2mg/kg |
|
|
